For fiscal year 2026, the Company is raising net revenue guidance by $10 million and maintaining Adjusted EBITDA and free cash flow guidance, as follows: Net revenue of $3.45 billion to $3.52 billion; Adjusted EBITDA of $680 million to $730 million; Free cash flow of $175 million to $225 million
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHCO:
- AdaptHealth price target raised to $11 from $9.50 at Jefferies
- AdaptHealth price target raised to $14 from $13 at Truist
- AdaptHealth Boosts Liquidity With New $1.1 Billion Credit Facility
- AdaptHealth announces refinancing of senior secured credit facility
- AdaptHealth rallies after CEO buys $4.4M of shares